Altrinsic Global Advisors LLC Morphic Holding, Inc. Transaction History

Altrinsic Global Advisors LLC

  • $2.13 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$36.25 - $52.02 $2.48 Million - $3.56 Million
-68,485 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$29.77 - $84.85 $595,400 - $1.7 Million
20,000 Added 41.25%
68,485 $4.33 Million
Q4 2020

Feb 16, 2021
BUY
$25.66 - $34.55 $128,300 - $172,750
5,000 Added 11.5%
48,485 $1.63 Million
Q2 2020

Aug 14, 2020
BUY
$12.65 - $29.57 $170,585 - $398,751
13,485 Added 44.95%
43,485 $1.18 Million
Q1 2020

May 14, 2020
BUY
$10.84 - $20.85 $325,200 - $625,500
30,000 New
30,000 $440,000

Others Institutions Holding MORF

# of Institutions
142
Shares Held
37.9M
Call Options Held
13.5K
Put Options Held
190K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email